°ü·Ã±â°ü ¼Ò½Ä

¹øÈ£ Á¦¸ñ µî·ÏÀÏ Ã·ºÎ Á¶È¸
870 2022³â ±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø ½ÉÆ÷Áö¾ö °³ÃÖ ¾È³» 2022-09-08 ÆÄÀÏ 271
869 [´ëÇѺ¹¸·¾ÏÇÐȸ] Á¦14ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú ½ÉÆ÷Áö¾ö °³ÃÖ (9.24) 2022-09-05 ÆÄÀÏ 298
868 [È£¾ÏÀç´Ü] 2023(Á¦33ȸ) »ï¼ºÈ£¾Ï»ó Èĺ¸ÀÚ Ãßõ °ø°í 2022-09-08 ÆÄÀÏ 212
867 [´ëÇѾϿ¬±¸Àç´Ü]Á¦2ȸ ¾Ï¿¬±¸ ¹Ú»çÇÐÀ§³í¹®»ó °ø¸ð ¾È³» 2022-09-05 ÆÄÀÏ 215
866 [´ëÇѾϿ¬±¸Àç´Ü]Á¦17ȸ ±èÁøº¹¾Ï¿¬±¸»ó °ø¸ð ¾È³» 2022-09-05 ÆÄÀÏ 217
865 [9/16] ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³] Ç׾Ͻžళ¹ß A-Z, Part 5. Antibody Drug Conjugates(ADC) 2022-09-02 ÆÄÀÏ 381
864 Á¦18Â÷ ¼¼°è³»½Ã°æº¹°­°æ¿Ü°ú »çÀüµî·Ï ¾È³» (~9/5) 2022-08-30 167
863 [»ï¼º¼­¿ïº´¿ø] Á¦1ȸ SMC PRO (Patient Reported Outcomes Symposium) °³ÃÖ ¾È³» (9/16) 2022-08-30 ÆÄÀÏ 216
862 [Çѱ¹°£´ãÃé¿Ü°úÇÐȸ] ½Ì±ÛÅäÇȽÉÆ÷Áö¿ò °³ÃÖ ¾È³» (16TH SINGLE TOPIC SYMPOSIUM (STS 2022)) 2022-08-16 ÆÄÀÏ 223
861 2022³â ±Û·Î¹ú ¹ÙÀÌ¿À ÄÜÆÛ·±½º 2022-08-10 ÆÄÀÏ 299
860 Á¦18Â÷ ¼¼°è³»½Ã°æº¹°­°æ¿Ü°ú Çмú´ëȸ ÃÊ·Ï Á¢¼ö ¾È³» (~8/12) 2022-08-08 226
859 2022³â ¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö(¿Â¶óÀÎ) °³ÃÖ ¾È³» 2022-08-10 319
858 [KSMO 2022] 15Â÷ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Çмú´ëȸ ¹× 2022 ±¹Á¦Çмú´ëȸ »çÀüµî·Ï ±â°£ ¿¬Àå 2022-08-03 254
857 [Çѱ¹º¸°ÇÀǷῬ±¸¿ø] ³ëÀÎ ¾ÏȯÀÚ Ä¡·á ÀÇ»ç°áÁ¤½Ã ÀÇ»çÀÇ °í·Á¿äÀÎ ¹× Àνĵµ Á¶»ç 2022-08-02 271
856 [Çѱ¹À¯ÀüüÇÐȸ] 2022 Á¦31ȸ KOGO Á¤±âÇмú´ëȸ °³ÃÖ ¾È³»(9/15-9/16) 2022-08-01 277
1 2 3 4 5 6 7 8 9 10 >